Related Experiment Video
Updated: Dec 17, 2025

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR-CHK2 interaction and prostate cancer survival
Huy Q Ta1, Natalia Dworak1, Melissa L Ivey1
1Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, United States.
Abstract:
We have previously demonstrated that checkpoint kinase 2 (CHK2) is a critical negative regulator of androgen receptor (AR) transcriptional activity, prostate cancer (PCa) cell growth, and androgen sensitivity. We have now uncovered that the AR directly interacts with CHK2 and ionizing radiation (IR) increases this interaction. This IR-induced increase in AR-CHK2 interactions requires AR phosphorylation and CHK2 kinase activity. PCa associated CHK2 mutants with impaired kinase activity reduced IR-induced AR-CHK2 interactions. The destabilization of AR - CHK2 interactions induced by CHK2 variants impairs CHK2 negative regulation of cell growth. CHK2 depletion increases transcription of DNAPK and RAD54, increases clonogenic survival, and increases resolution of DNA double strand breaks. The data support a model where CHK2 sequesters the AR through direct binding decreasing AR transcription and suppressing PCa cell growth. CHK2 mutation or loss of expression thereby leads to increased AR transcriptional activity and survival in response to DNA damage.
Insights
Checkpoint kinase 2 (CHK2) directly binds androgen receptor (AR), suppressing prostate cancer growth. DNA damage enhances this interaction, but CHK2 mutations disrupt it, promoting cancer cell survival.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Checkpoint kinase 2 (CHK2) is a known negative regulator of androgen receptor (AR) transcriptional activity, prostate cancer (PCa) cell growth, and androgen sensitivity.
- Previous studies established CHK2's role in regulating AR and PCa progression.
Purpose of the Study:
- To investigate the direct interaction between AR and CHK2.
- To elucidate the role of ionizing radiation (IR) in modulating AR-CHK2 interactions.
- To determine the impact of CHK2 kinase activity and mutations on AR regulation and PCa cell growth.
Main Methods:
- Co-immunoprecipitation assays to detect AR-CHK2 interactions.
- Analysis of AR phosphorylation and CHK2 kinase activity.
- Assessment of CHK2 mutant effects on AR-CHK2 binding and cell growth.
- Evaluation of CHK2 depletion effects on DNA repair genes and cell survival.
Main Results:
- AR directly interacts with CHK2, and this interaction is significantly increased by ionizing radiation (IR).
- IR-induced AR-CHK2 interaction enhancement is dependent on AR phosphorylation and CHK2 kinase activity.
- Prostate cancer-associated CHK2 mutants with reduced kinase activity show diminished IR-induced AR-CHK2 interactions, leading to impaired negative regulation of cell growth.
- CHK2 depletion results in increased transcription of DNA repair genes (DNAPK, RAD54), enhanced clonogenic survival, and accelerated resolution of DNA double-strand breaks.
Conclusions:
- CHK2 acts as a negative regulator of AR transcriptional activity and PCa cell proliferation by directly sequestering AR.
- Disruption of AR-CHK2 interaction, through CHK2 mutation or loss of expression, leads to increased AR transcriptional activity and promotes cancer cell survival, particularly in response to DNA damage.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

